Philter Labs has a total of 39 patents globally, out of which 12 have been granted. Of these 39 patents, more than 92% patents are active. The United States is where Philter Labs has filed the maximum number of patents. Parallelly, the USA seems to be the main focused R&D
Syqe Medical has a total of 251 patents globally, out of which 118 have been granted. Of these 251 patents, more than 87% patents are active. The USA is where Syqe Medical has filed the maximum number of patents, followed by Israel. Parallelly, the United States seems to be the
Patent filings in most of the technological aspects of Cannabis have taken an upward surge from 2014 onwards. This would be in line with the start of Cannabis being legalized in different areas. Now, as Cannabis is being integrated into different product lines, innovation in areas such as Sensory Technologies,
The cannabis plant contains more than 113 cannabinoids including the CBD and THC. Scientists have identified more than 550 chemicals in cannabis in general including components like terpenes. Different extraction techniques are being used to concentrate chemicals of interest. Companies are aggressively researching in the extraction of cannabinoids especially in
Currently, a combination of marijuana cannabinoids including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is used as a drug to treat muscle spasticity in patients with Multiple Sclerosis (MS). Earlier there wasn’t any cure for multiple sclerosis but a combination therapy using THC and CBD results in amelioration of EAE and interestingly
Innovation in the Cannabis domain is concentrated around Delivery systems as the industry is striving to make cannabinoid-based formulations easy, safe, and effective for consumption. We have divided the patent filed in Delivery Systems’ into three sections: Routes of Administration (39 Patent Families) Route of Administration (ROA) refers to the
High patent filing activity is expected in the product line of cannabinoids. Cannabinoids have been in use for medical purposes for very long. However, after deregulation, researchers have been finding more and more uses of these compounds in product lines of different sectors viz Health & Wellness, Vapes, and Beverages
The improvement in pharmacokinetics would eventually result in an enhanced onset and duration time. The onset and duration depend on multiple factors ranging from the drug composition to the route of administration. But in the case of cannabinoid, it’s a big obstacle because of its lipophilic nature. It only shows
Natural cannabis has a harsh smell and tastes bitter as they have terpenes and flavonoids in it. So, to enhance the sensory experience for consuming cannabis it’s required to mask its bad organoleptic properties [smell, taste, etc.]. For that purpose, flavors are being added to cannabis to significantly suppress the
The exhibit below shows the priority country (first filing in any patent family) where the research was originated. Usually, the entities file for patents in the same country where they have their R&D centers. So, in a way, it showcases in which countries the R&D hubs for Cannabis are located.
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.